A decline in breast-cancer incidence [13]

New England Journal of Medicine

Volumn 357, Issue 5, 2007, Pages 509-

  Elfenbein, Gerald J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR;

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; HORMONE SUBSTITUTION; HUMAN; LETTER; MENOPAUSAL SYNDROME; PRIORITY JOURNAL;

EID: 34547637233     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc071391     Document Type: Letter

References (19)

1. PM Ravdin KA Cronin N Howlader The decrease in breast-cancer incidence in 2003 in the United States N Engl J Med 356 2007 1670 1674
2. JE Rossouw GL Anderson RL Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
3. RT Chlebowski SL Hendrix RD Langer Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial JAMA 289 2003 3243 3253
4. GL Anderson M Limacher AR Assaf Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
5. The ups and downs of HRT. Montreal: IMS Health, Canada, 2006. (Accessed July 12, 2007, at http://www.imshealth.com/vgn/images/portal/cit_40000873/6/1/79032750Insights01En061127.pdf .)
6. Public Health Agency of Canada. Cancer surveillance on-line. (Accessed July 12, 2007, at http://dsol-smed.phac-aspc.gc.ca/dsol-smed/cancer/index_e.html .)
7. Cancer in Norway 2005. Oslo: Cancer Registry of Norway (Kreftregisteret), 2006.
8. Cancer incidence in Sweden 2005. Stockholm: National Board of Health and Welfare (Socialstyrelsen), 2007.
9. P-H Zahl BH Strand J Maehlen Breast cancer incidence in Norway and Sweden during introduction of nationwide screening: prospective cohort study BMJ 328 2004 921 924
10. Robbins AS, Clarke CA. Regional changes in hormone therapy use and breast cancer incidence, California, 2001−2004. J Clin Oncol (in press).
11. California Health Interview Survey. (Accessed July 12, 2007, athttp://www.chis.ucla.edu.)
12. KM Brett JH Madans Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study Am J Epidemiol 145 1997 536 545
13. LB Signorello MK Hargreaves MD Steinwandel Southern Community Cohort Study: establishing a cohort to investigate health disparities J Natl Med Assoc 97 2005 972 979
14. Wei F, Miglioretti DL, Connelly MT, et al. Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. In: Vogt TM, Wagner EH, eds. Health care systems as research platforms: the cancer research network. Journal of the National Cancer Institute monographs. No. 35. Bethesda, MD: Oxford University Press, 2005:106-12.
15. JJ Hillman IH Zuckerman E Lee The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program J Womens Health (Larchmt) 13 2004 986 992
16. RT Chlebowski SL Hendrix RD Langer Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial JAMA 289 2003 3243 3253
17. Robbins AS, Clarke CA. Regional changes in hormone therapy use and breast cancer incidence, California, 2001−2004. J Clin Oncol (in press).
18. Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilization of hormone replacement therapy. Breast Cancer Res Treat (in press).
19. A Jemal E Ward MJ Thun Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women Breast Cancer Res 9 2007 R28